Cardiac arrest after topical application of lidocaine during microneedling procedure: A rare case

2020 ◽  
Vol 33 (6) ◽  
Author(s):  
Morteza Safi ◽  
Isa Khaheshi ◽  
Fatemeh Mottaghizadeh ◽  
Mohammadreza Tabary ◽  
Nasser Malekpour Alamdari
2019 ◽  
Vol 11 (1) ◽  
pp. 23-27 ◽  
Author(s):  
Verena Isak ◽  
Tobias Beerli ◽  
Antonio Cozzio ◽  
Lukas Flatz

Due to its antibacterial actions, silver sulfadiazine is widely used as a topical agent in the treatment of wounds, including burns. Widespread or prolonged topical application of silver sulfadiazine dressings can lead to argyria including systemic symptoms due to the resorption of silver. Here, we report a patient experiencing localized argyria due to sunlight exposure after topical use of silver sulfadiazine cream on his face.


2012 ◽  
Vol 171 (12) ◽  
pp. 1851-1854 ◽  
Author(s):  
Emma L. Houston ◽  
Ramasubramanyan Chandrasekar
Keyword(s):  

Cureus ◽  
2020 ◽  
Author(s):  
Sowjanya Kapaganti ◽  
Shahryar Anwar Ansari ◽  
Richard Saba ◽  
Ahmed Elkhouly ◽  
Mohab Hassib

CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A220
Author(s):  
Harsimran Brar ◽  
James Bradley ◽  
William Smith

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Xiaoqing Zhang ◽  
Wenwen Zhai ◽  
Min Li ◽  
Xiangyang Guo

Abstract Background Vancomycin (VCM) is effective in fighting Gram-positive bacteria related severe infections, and topical application of VCM powder is widely used in orthopedic surgery to prevent wound infection. However, VCM could lead to infusion rate-dependent antibody-and complement-independent anaphylaxis reaction by inducing direct release of histamine. Case presentation We retrospectively analyzed seven cases of severe hypotension and shock during wound closure or immediately after orthopedic surgery with unidentifiable reasons. We found that these cases were all associated with local application of VCM powder during wound closure process. Two patients experienced sudden cardiac arrest. Most of the cases (6/7) with circulatory collapse were discharged without severe sequelae. While one case with application of 3 g VCM developed cardiac arrest and remained in a coma due to hypoxic-hypoxic encephalopathy. The clinical presentations and the time of the shock onset were considered to be related with a VCM induced anaphylaxis reaction. However, as this was a retrospective study, and there was no laboratory examination performed, the conclusion was made upon differential diagnosis based on clinical manifestations and the timing of the shock. Conclusions Local application of VCM may not be as safe as was once believed and may lead to a related anaphylaxis. As VCM induced infusion-rate dependent, non-IgE mediated anaphylaxis is characterized by delayed occurrence, severe hypotension and even circulatory collapse, surgeons and anesthesiologists should be extra vigilant during and after VCM application.


Sign in / Sign up

Export Citation Format

Share Document